AAAAAA
Results: 1-25/160
Authors:
WARZOCHA K
RIBEIRO P
BIENVENU J
ROY P
CHARLOT C
RIGAL D
COIFFIER B
SALLES G
Citation: K. Warzocha et al., GENETIC POLYMORPHISMS IN THE TUMOR-NECROSIS-FACTOR LOCUS INFLUENCE NON-HODGKINS-LYMPHOMA OUTCOME, Blood, 91(10), 1998, pp. 3574-3581
Authors:
SALLES G
COIFFIER B
Citation: G. Salles et B. Coiffier, HISTOLOGIC TRANSFORMATION IN FOLLICULAR LYMPHOMA, Annals of oncology, 9(8), 1998, pp. 803-805
Authors:
COIFFIER B
Citation: B. Coiffier, MARGINAL ZONE LYMPHOMAS, Annals of oncology, 9, 1998, pp. 11-11
Authors:
DUMONTET C
NEIDHARTBERNARD EM
MOULLET I
THIEBLEMONT C
ESPINOUSE D
BOUAFIA F
SALLES G
COIFFIER B
Citation: C. Dumontet et al., SHORT INTENSIVE TREATMENT WITH HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) WITH 2 OR 3 POOR PROGNOSTIC FACTORS, Annals of oncology, 9, 1998, pp. 527-527
Authors:
COIFFIER B
Citation: B. Coiffier, NON-HODGKINS-LYMPHOMA IN THE ELDERLY - THERAPEUTICS STRATEGIES AND RESULTS IN CLINICAL-TRIALS, Annals of oncology, 9, 1998, pp. 19-19
Authors:
COIFFIER B
Citation: B. Coiffier, RITUXIMAB IN DIFFUSE LARGE B-CELL AND MANTLE CELL LYMPHOMAS, Annals of oncology, 9, 1998, pp. 20-20
Authors:
MOULLET I
SALLES G
KETTERER N
DUMONTET C
BOUAFIA F
NEIDHARTBERARD EM
THIEBLEMONT C
FELMAN P
COIFFIER B
Citation: I. Moullet et al., FREQUENCY AND SIGNIFICANCE OF ANEMIA IN NON-HODGKINS-LYMPHOMA PATIENTS, Annals of oncology, 9(10), 1998, pp. 1109-1115
Authors:
HAIOUN C
LEPAGE E
GISSELBRECHT C
COIFFIER B
DOYEN C
MOREL P
ATTAL M
TILLY H
DECONINCK E
GAULARD P
REYES F
Citation: C. Haioun et al., HIGH-DOSE THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN PARTIAL-RESPONSE AFTER FIRST-LINE INDUCTION THERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA, Annals of oncology, 9, 1998, pp. 5-8
Authors:
SAMAHA H
DUMONTET C
KETTERER N
MOULLET I
THIEBLEMONT C
BOUAFIA F
CALLETBAUCHU E
FELMAN P
BERGER F
SALLES G
COIFFIER B
Citation: H. Samaha et al., MANTLE CELL LYMPHOMA - A RETROSPECTIVE STUDY OF 121 CASES, Leukemia, 12(8), 1998, pp. 1281-1287
Authors:
CHESON BD
SORENSEN JM
VENA DA
MONTELLO MJ
BARRET JA
DAMASIO E
TALLMAN M
ANNINO L
CONNERS J
COIFFIER B
LAURIA F
Citation: Bd. Cheson et al., TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - A REPORTOF 979 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3007-3015
Authors:
SOLALCELIGNY P
LEPAGE E
BROUSSE N
TENDLER CL
BRICE P
HAIOUN C
GABARRE J
PIGNON B
TERTIAN G
BOUABDALLAH R
ROSSI JF
DOYEN C
COIFFIER B
Citation: P. Solalceligny et al., DOXORUBICIN-CONTAINING REGIMEN WITH OR WITHOUT INTERFERON-ALPHA-2B FOR ADVANCED FOLLICULAR LYMPHOMAS - FINAL ANALYSIS OF SURVIVAL AND TOXICITY IN THE GROUPE-DETUDE-DES-LYMPHOMES-FOLLICULAIRES-86 TRIAL, Journal of clinical oncology, 16(7), 1998, pp. 2332-2338
Authors:
BLAY JY
CONROY T
CHEVREAU C
THYSS A
QUESNEL N
EGHBALI H
BOUABDALLAH R
COIFFIER B
WAGNER JP
LEMEVEL A
DRAMAISMARCEL D
BAUMELOU E
CHAUVIN F
BIRON P
Citation: Jy. Blay et al., HIGH-DOSE METHOTREXATE FOR THE TREATMENT OF PRIMARY CEREBRAL LYMPHOMAS - ANALYSIS OF SURVIVAL AND LATE NEUROLOGIC TOXICITY IN A RETROSPECTIVE SERIES, Journal of clinical oncology, 16(3), 1998, pp. 864-871
Authors:
COIFFIER B
Citation: B. Coiffier, WHICH TREATMENT FOR MANTLE-CELL LYMPHOMA PATIENTS IN 1998, Journal of clinical oncology, 16(1), 1998, pp. 3-5
Authors:
DUMONTET C
KETTERER N
ESPINOUSE D
NEIDHARDT EM
MOULLET I
THIEBLEMONT C
SALLES G
COIFFIER B
Citation: C. Dumontet et al., REDUCED PROGRESSION-FREE SURVIVAL IN ELDERLY PATIENTS RECEIVING INTENSIFICATION WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL REINFUSION FOR MULTIPLE-MYELOMA, Bone marrow transplantation, 21(10), 1998, pp. 1037-1041
Authors:
ARCHIMBAUD E
PHILIP I
COIFFIER B
MICHALLET M
SALLES G
SEBBAN C
ROUBI N
LOPEZ F
BESSUEILLE L
MAZARS P
GERARD C
HANANIA E
RAMANATHAN R
READING C
JUTTNER C
ATKINSON K
PHILIP T
Citation: E. Archimbaud et al., SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( THY), Bone marrow transplantation, 21, 1998, pp. 52-52
Authors:
BRICE P
DIVINE M
COIFFIER B
LEBLOND V
SIMON M
DEVIDAS A
SIMON D
ROHRLICH P
FERME C
Citation: P. Brice et al., DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN REFRACTORY AND EARLY DISSEMINATED RELAPSE FROM HODGKINS-DISEASE (HD) - A PILOT-STUDY FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE/, Bone marrow transplantation, 21, 1998, pp. 573-573
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH RP-93/, Bone marrow transplantation, 21, 1998, pp. 585-585
Authors:
HAIOUN C
LEPAGE E
GISSELBRECHT C
COIFFIER B
DOYEN C
MOREL P
ARTAL M
TILLY H
DECONINCK E
GAULARD P
REYES F
Citation: C. Haioun et al., AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 94 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL, Bone marrow transplantation, 21, 1998, pp. 599-599
Authors:
MOUNIER N
MOREL P
HAIOUN C
COIFFIER B
TILLY H
CHATELAIN C
LEDERLIN P
THYSS A
HERBRECHT R
GISSELBRECHT C
LEPAGE E
Citation: N. Mounier et al., A MULTIVARIATE-ANALYSIS OF THE SURVIVAL OF PATIENTS WITH AGGRESSIVE LYMPHOMA - VARIATIONS IN THE PREDICTIVE VALUE OF PROGNOSTIC FACTORS DURING THE COURSE OF THE DISEASE, Cancer, 82(10), 1998, pp. 1952-1962
Authors:
COIFFIER B
SALLES G
Citation: B. Coiffier et G. Salles, LYMPHOMAS - 1997, A VALUABLE YEAR, Bulletin du cancer, 85(1), 1998, pp. 45-47
Authors:
FELMAN P
CALLETBAUCHU E
BASEGGIO L
MOREL D
BERGER F
PAGES J
COIFFIER B
SALLES G
COEUR P
Citation: P. Felman et al., SPLENIC MARGINAL ZONE LYMPHOMAS (OTHER THAN SLVL) MASQUERADING AS ATYPICAL CLL, British Journal of Haematology, 102(1), 1998, pp. 127-127
Authors:
WARZOCHA K
RIBEIRO P
BIENVENU J
ROY P
CHARLOT C
COIFFIER B
SALLES G
Citation: K. Warzocha et al., INHERITED SUSCEPTIBILITY FOR INCREASE TNF PRODUCTION IMPAIRS LYMPHOMAPATIENTS OUTCOME, British Journal of Haematology, 102(1), 1998, pp. 144-144
Authors:
BOSLY A
SONET A
SALLES G
BRICE P
HAIOUN C
KERNEIS Y
FERRANT A
TILLY H
LEDERLIN P
PLANTIER I
SEBBAN C
GISSELBRECHT C
COIFFIER B
Citation: A. Bosly et al., SUPERIORITY OF LATE OVER EARLY INTENSIFICATION IN RELAPSING REFRACTORY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A RANDOMIZED STUDY FROM THE GELA - LNH-RP-93/, British Journal of Haematology, 102(1), 1998, pp. 148-148
Authors:
FORAN JM
ROHATINER AZS
CUNNINGHAM D
POPESCU R
SOLAICELIGNY P
CAVALLI F
COIFFIER B
JOHNSON P
GISSELBRECHT C
HAIOUN C
BESSELL E
SWEETENHAM J
RADFORD J
BENZOHRA A
LISTER TA
Citation: Jm. Foran et al., IMMUNOTHERAPY OF MANTLE CELL LYMPHOMA (MCL), LYMPHOPLASMACYTOID LYMPHOMA (LPC) AND WALDENSTROMS MACROGLOBULINEMIA (WM), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) WITH RITUXIMAB (IDEC-C288) - PRELIMINARY-RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER TRIAL, British Journal of Haematology, 102(1), 1998, pp. 149-149
Authors:
KETTERER N
SALLES G
RABA M
ELJAAFARICORBIN A
ESPINOUSE D
TREMISI P
DUMONTET C
MOULLET I
NEIDHARDTBERARD EM
BOUAFIA F
COIFFIER B
Citation: N. Ketterer et al., HIGH CD34(-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATIONS() CELL COUNTS DECREASE HEMATOLOGICAL TOXICITY OF PERIPHERAL), British Journal of Haematology, 102(1), 1998, pp. 204-204